207 related articles for article (PubMed ID: 26325253)
1. Efficacy of Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema After Vitrectomy.
Watanabe A; Tsuzuki A; Arai K; Gekka T; Kohzaki K; Tsuneoka H
J Ocul Pharmacol Ther; 2016; 32(1):38-43. PubMed ID: 26325253
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of postvitrectomy intravitreal triamcinolone therapy for diabetic macular edema.
Costa JF; Sousa K; Marques JP; Marques M; Cachulo ML; Silva R; Gomes N; Figueira J
Eur J Ophthalmol; 2016 Aug; 26(5):485-90. PubMed ID: 26951531
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
4. Deferred intravitreal triamcinolone in diabetic eyes after phacoemulsification.
Campos A; Beselga D; Mendes S; Campos J; Neves A; Sousa P
J Ocul Pharmacol Ther; 2014 Nov; 30(9):717-28. PubMed ID: 25111757
[TBL] [Abstract][Full Text] [Related]
5. Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema.
Lee HY; Lee SY; Park JS
Korean J Ophthalmol; 2009 Sep; 23(3):153-8. PubMed ID: 19794940
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.
Browning DJ; Fraser CM; Powers ME
Ophthalmology; 2006 Oct; 113(10):1713-9. PubMed ID: 16889833
[TBL] [Abstract][Full Text] [Related]
7. Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.
Pessoa B; Coelho J; Correia N; Ferreira N; Beirão M; Meireles A
Ophthalmic Res; 2018; 59(2):68-75. PubMed ID: 29248913
[TBL] [Abstract][Full Text] [Related]
8. Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema.
Kang SW; Sa HS; Cho HY; Kim JI
Arch Ophthalmol; 2006 May; 124(5):653-8. PubMed ID: 16682586
[TBL] [Abstract][Full Text] [Related]
9. Vitrectomy combined with intravitreal triamcinolone acetonide injection and macular laser photocoagulation for nontractional diabetic macular edema.
Kim JH; Kang SW; Ha HS; Kim JR
Korean J Ophthalmol; 2013 Jun; 27(3):186-93. PubMed ID: 23730111
[TBL] [Abstract][Full Text] [Related]
10. Time course of changes in retinal thickness and visual acuity after intravitreal triamcinolone acetonide for diffuse diabetic macular edema with and without previous macular laser treatment.
Patelli F; Fasolino G; Radice P; Russo S; Zumbo G; DI Tizio FM; Frisone G; Marchi S
Retina; 2005; 25(7):840-5. PubMed ID: 16205561
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of vitrectomy versus intravitreous triamcinolone for diabetic macular edema on randomized paired-eyes.
Doi N; Sakamoto T; Sonoda Y; Yasuda M; Yonemoto K; Arimura N; Uchino E; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2012 Jan; 250(1):71-8. PubMed ID: 21853229
[TBL] [Abstract][Full Text] [Related]
12. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ
Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632
[TBL] [Abstract][Full Text] [Related]
13. Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema.
Zein WM; Noureddin BN; Jurdi FA; Schakal A; Bashshur ZF
Retina; 2006 Feb; 26(2):137-42. PubMed ID: 16467667
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone intravitreal implant in vitrectomized versus nonvitrectomized eyes for treatment of patients with persistent diabetic macular edema.
Medeiros MD; Alkabes M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
J Ocul Pharmacol Ther; 2014 Nov; 30(9):709-16. PubMed ID: 25259834
[TBL] [Abstract][Full Text] [Related]
15. Comparison of vitrectomized with nonvitrectomized eyes after subtenon injection of triamcinolone acetonide to treat diabetic macular edema: Retrospective comparative Analysis of an interventional case series.
Pak KY; Choi BS; Park SW; Byon IS; Lee JE
Indian J Ophthalmol; 2017 Jun; 65(6):488-492. PubMed ID: 28643714
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.
Liu Q; Hu Y; Yu H; Yuan L; Hu J; Atik A; Guan M; Li D; Li X; Tang S
Retina; 2015 Feb; 35(2):272-9. PubMed ID: 25105313
[TBL] [Abstract][Full Text] [Related]
17. [Intravitreal Triamcinolone Acetonide for Persistent Diabetic Macular Edema after Vitrectomy].
Ichio A; Sugimoto M; Kondo M
Nippon Ganka Gakkai Zasshi; 2016 Jun; 120(6):429-38. PubMed ID: 27487715
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema.
Wang YS; Li X; Wang HY; Zhang ZF; Li MH; Su XN
Chin Med J (Engl); 2011 Feb; 124(3):352-8. PubMed ID: 21362332
[TBL] [Abstract][Full Text] [Related]
19. The role of macular hydration in the evaluation of the effect of intravitreal triamcinolone on visual acuity in eyes with diabetic macular edema.
Sonmez K; Tezel TH; Kaplan HJ
Int Ophthalmol; 2013 Feb; 33(1):15-25. PubMed ID: 22890369
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial.
Gillies MC; McAllister IL; Zhu M; Wong W; Louis D; Arnold JJ; Wong TY
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2322-8. PubMed ID: 20019369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
